- Home
- TOI vs QTRX Comparison
TOI vs QTRX Comparison
Compare TOI & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOI
- QTRX
- Stock Information
- Founded
- TOI 2007
- QTRX 2007
- Country
- TOI United States
- QTRX United States
- Employees
- TOI N/A
- QTRX N/A
- Industry
- TOI Medical/Nursing Services
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- TOI Health Care
- QTRX Industrials
- Exchange
- TOI Nasdaq
- QTRX Nasdaq
- Market Cap
- TOI 266.8M
- QTRX 233.5M
- IPO Year
- TOI N/A
- QTRX 2017
- Fundamental
- Price
- TOI $2.39
- QTRX $6.12
- Analyst Decision
- TOI
- QTRX Buy
- Analyst Count
- TOI 0
- QTRX 5
- Target Price
- TOI N/A
- QTRX $15.60
- AVG Volume (30 Days)
- TOI 1.9M
- QTRX 763.5K
- Earning Date
- TOI 08-12-2025
- QTRX 08-07-2025
- Dividend Yield
- TOI N/A
- QTRX N/A
- EPS Growth
- TOI N/A
- QTRX N/A
- EPS
- TOI N/A
- QTRX N/A
- Revenue
- TOI $403,152,000.00
- QTRX $135,688,000.00
- Revenue This Year
- TOI $23.95
- QTRX N/A
- Revenue Next Year
- TOI N/A
- QTRX $14.49
- P/E Ratio
- TOI N/A
- QTRX N/A
- Revenue Growth
- TOI 17.64
- QTRX 7.71
- 52 Week Low
- TOI $0.13
- QTRX $4.05
- 52 Week High
- TOI $3.50
- QTRX $16.74
- Technical
- Relative Strength Index (RSI)
- TOI 38.68
- QTRX 55.97
- Support Level
- TOI $2.28
- QTRX $5.98
- Resistance Level
- TOI $2.87
- QTRX $6.76
- Average True Range (ATR)
- TOI 0.24
- QTRX 0.52
- MACD
- TOI -0.10
- QTRX 0.09
- Stochastic Oscillator
- TOI 1.24
- QTRX 56.46
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.